| Closed |
SWOG-8039 |
A Trial of CT, RT & Surgery for Locally Advanced Carcinoma of the Maxillary Sinus |
2/9/1981 |
5/10/1982 |
|
|
|
| Closed |
SWOG-8211 |
Evaluation of Cis-Diamminedichloroplatinum in Disseminated Gastric Adenocarcinoma |
8/11/1982 |
10/3/1984 |
|
|
|
| Closed |
SWOG-7864 |
Combined Modality Treatment of Residual Gastric Carcinoma Following Initial Surgery |
4/26/1978 |
10/4/1979 |
|
|
|
| Closed |
SWOG-7937 |
Evaluation of m-AMSA in Metastatic Carcinoma of the GU Tract Except Renal Carcinoma |
11/20/1979 |
9/10/1982 |
|
|
|
| Closed |
SWOG-8816 |
Study of 13-cis Retinoic Acid (Accutane) Plus rIFN-A (Roferon-A) in Mycosis Fungoides |
5/15/1989 |
1/1/1993 |
50% |
|
|
| Closed |
SWOG-8063 |
Evaluation of Anguidine (NSC-141537) in Refractory Adult Acute Nonlymphocytic Leukemia |
4/22/1980 |
4/14/1981 |
|
|
|
| Closed |
SWOG-7940 |
Evaluation of 5-FU vs. A Phase II Drug in Metastatic Adeno- carcinoma of the Large Bowel |
2/27/1980 |
5/5/1982 |
|
|
|
| Closed |
SWOG-7940/44 |
Appendix VI-SWOG-7940, Evaluation of AZQ in Metastatic Adenocarcinoma of the Large Bowel |
9/23/1980 |
6/4/1981 |
|
|
|
| Closed |
SWOG-7940/45 |
Appendix VI-SWOG-7940, Evaluation of AZQ in Metastatic Adenocarcinoma of the Large Bowel |
6/4/1981 |
5/5/1982 |
|
|
|
| Closed |
SWOG-8369 |
Combination Chemotherapy with Mitoxantrone, Cis-Platinum and MGBG for Refractory Lymphoma |
10/18/1983 |
7/15/1986 |
|
|
|
| Closed |
SWOG-8752 |
A Phase II Study of Recombinant Tumor Necrosis (rTNF) in Patients with Endometrial Cancer |
9/15/1988 |
7/15/1990 |
17% |
|
|
| Closed |
SWOG-7841 |
Phase II-III Comparison of FAM vs DHAD in the Treatment of Advanced Gastric Adenocarcinoma |
2/16/1979 |
8/25/1982 |
|
|
|
| Closed |
SWOG-8954 |
Evaluation of the L-17M Protocol in the Management of Patients with Lymphoblastic Lymphoma |
4/15/1990 |
5/15/1997 |
74% |
|
|
| Closed |
SWOG-7908 |
Vinblastine Sulfate (NSC-49842) in the Management of Resistant Chronic Myelogenous Leukemia |
4/9/1979 |
10/17/1979 |
|
|
|
| Closed |
SWOG-8999 |
Evaluation of Radiation Treatment Following Surgical Resection of Solitary Brain Metastasis |
8/15/1989 |
12/15/1990 |
4% |
|
|
| Closed |
SWOG-9101 |
Evaluation of Edatrexate in Patients with Advanced or Recurrent Bladder Carcinoma, Phase II |
11/15/1992 |
11/15/1993 |
15% |
|
|
| Closed |
SWOG-8011 |
Evaluation of Dihydroxyanthracenedione (DHAD) in Patients with Advanced Renal Cell Carcinoma |
7/2/1980 |
4/14/1981 |
|
|
|
| Closed |
SWOG-9001 |
Study of Alpha Interferon Plus 5-Fluorouracil in Patients with Advanced Renal Cell Carcinoma |
|
7/15/1990 |
|
|
|
| Closed |
SWOG-7912 |
Gallium Nitrate (NSC-15200) in Patients with Malignant Lymphoma - Hodgkin's and Non Hodgkin's |
5/11/1979 |
4/14/1981 |
|
|
|
| Closed |
SWOG-9428 |
Ancillary |
5/15/1994 |
12/1/1999 |
36% |
|
|
